Trial
NCT00759642
Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Kansas Medical Center
Collaborators
—
Condition
Metastatic Breast Cancer
Intervention
lapatinib
Why stopped
IRB decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-07-01